Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.
Clinical trial NCT04625985 · COMPLETED
Trial details
- NCT number
- NCT04625985
- Sponsor
- Laboratorios Silanes S.A. de C.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2021-03-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.